Eicosanoids in inflammation in the blood and the vessel

A Yamaguchi, E Botta, M Holinstat - Frontiers in pharmacology, 2022 - frontiersin.org
Polyunsaturated fatty acids (PUFAs) are structural components of membrane phospholipids
in cells. PUFAs regulate cellular function through the formation of derived lipid mediators …

Platelet signaling and disease: targeted therapy for thrombosis and other related diseases

J Yeung, W Li, M Holinstat - Pharmacological reviews, 2018 - ASPET
Platelets are essential for clotting in the blood and maintenance of normal hemostasis.
Under pathologic conditions such as atherosclerosis, vascular injury often results in …

[HTML][HTML] The biological role of arachidonic acid 12-lipoxygenase (ALOX12) in various human diseases

Z Zheng, Y Li, G Jin, T Huang, M Zou, S Duan - Biomedicine & …, 2020 - Elsevier
ALOX12 encodes arachidonic acid 12-lipoxygenase that acts on different polyunsaturated
fatty acid substrates to produce biologically active lipid mediators including eicosanes and …

Microvascular thrombosis: experimental and clinical implications

MA Bray, SE Sartain, J Gollamudi, RE Rumbaut - Translational Research, 2020 - Elsevier
A significant amount of clinical and research interest in thrombosis is focused on large
vessels (eg, stroke, myocardial infarction, deep venous thrombosis, etc.); however …

Regulation of platelet function and thrombosis by omega-3 and omega-6 polyunsaturated fatty acids

R Adili, M Hawley, M Holinstat - Prostaglandins & other lipid mediators, 2018 - Elsevier
Thrombosis is the most common underlying pathology responsible for morbidity and
mortality in cardiovascular disease (CVD). Platelet adhesion, activation, and aggregation …

Synthesis and significance of arachidonic acid, a substrate for cyclooxygenases, lipoxygenases, and cytochrome P450 pathways in the tumorigenesis of glioblastoma …

J Korbecki, E Rębacz-Maron, P Kupnicka, D Chlubek… - Cancers, 2023 - mdpi.com
Simple Summary Glioblastoma multiforme is a brain tumor with a very unfavorable
prognosis, where the vast majority of patients do not survive a year after diagnosis. One line …

First selective 12-LOX inhibitor, ML355, impairs thrombus formation and vessel occlusion in vivo with minimal effects on hemostasis

R Adili, BE Tourdot, K Mast, J Yeung… - … , and vascular biology, 2017 - Am Heart Assoc
Objective—Adequate platelet reactivity is required for maintaining hemostasis. However,
excessive platelet reactivity can also lead to the formation of occlusive thrombi. Platelet 12 …

The expansive role of oxylipins on platelet biology

J Yeung, M Hawley, M Holinstat - Journal of molecular medicine, 2017 - Springer
In mammals, three major oxygenases, cyclooxygenases (COXs), lipoxygenases (LOXs), and
cytochrome P450 (CYP450), generate an assortment of unique lipid mediators (oxylipins) …

Platelet ACKR3/CXCR7 favors antiplatelet lipids over an atherothrombotic lipidome and regulates thromboinflammation

M Cebo, K Dittrich, X Fu, MC Manke… - Blood, The Journal …, 2022 - ashpublications.org
Platelet ACKR3/CXCR7 surface expression is enhanced and influences prognosis in
coronary artery disease (CAD) patients, who exhibit a distinct atherothrombotic platelet …

Antiplatelet strategies: past, present, and future

L Stanger, A Yamaguchi, M Holinstat - Journal of Thrombosis and …, 2023 - Elsevier
Antiplatelet therapy plays a critical role in the prevention and treatment of major
cardiovascular diseases triggered by thrombosis. Since the 1900s, significant progress in …